BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 15471896)

  • 21. Lysophosphatidic acid receptor 2/3-mediated IL-8-dependent angiogenesis in cervical cancer cells.
    Chen RJ; Chen SU; Chou CH; Lin MC
    Int J Cancer; 2012 Aug; 131(4):789-802. PubMed ID: 21964883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous RGS proteins attenuate Galpha(i)-mediated lysophosphatidic acid signaling pathways in ovarian cancer cells.
    Hurst JH; Henkel PA; Brown AL; Hooks SB
    Cell Signal; 2008 Feb; 20(2):381-9. PubMed ID: 18083345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysophosphatidic acid promotes survival of androgen-insensitive prostate cancer PC3 cells via activation of NF-kappaB.
    Raj GV; Sekula JA; Guo R; Madden JF; Daaka Y
    Prostate; 2004 Oct; 61(2):105-13. PubMed ID: 15305333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion.
    Sengupta S; Kim KS; Berk MP; Oates R; Escobar P; Belinson J; Li W; Lindner DJ; Williams B; Xu Y
    Oncogene; 2007 May; 26(20):2894-901. PubMed ID: 17130843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells.
    Wang HQ; Altomare DA; Skele KL; Poulikakos PI; Kuhajda FP; Di Cristofano A; Testa JR
    Oncogene; 2005 May; 24(22):3574-82. PubMed ID: 15806173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of lysophosphatidylglycerol on several signaling molecules in OVCAR-3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor.
    Park KS; Kim MK; Im DS; Bae YS
    Biochem Pharmacol; 2007 Mar; 73(5):675-81. PubMed ID: 17161826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells.
    Do TV; Symowicz JC; Berman DM; Liotta LA; Petricoin EF; Stack MS; Fishman DA
    Mol Cancer Res; 2007 Feb; 5(2):121-31. PubMed ID: 17314270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysophosphatidic acid mediates interleukin-8 expression in human endometrial stromal cells through its receptor and nuclear factor-kappaB-dependent pathway: a possible role in angiogenesis of endometrium and placenta.
    Chen SU; Lee H; Chang DY; Chou CH; Chang CY; Chao KH; Lin CW; Yang YS
    Endocrinology; 2008 Nov; 149(11):5888-96. PubMed ID: 18617617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysophosphatidic acid protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis.
    Chen J; Baydoun AR; Xu R; Deng L; Liu X; Zhu W; Shi L; Cong X; Hu S; Chen X
    Stem Cells; 2008 Jan; 26(1):135-45. PubMed ID: 17932426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway.
    Estrella VC; Eder AM; Liu S; Pustilnik TB; Tabassam FH; Claret FX; Gallick GE; Mills GB; Wiener JR
    Int J Oncol; 2007 Aug; 31(2):441-9. PubMed ID: 17611702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway.
    Li Y; Sarkar FH
    Clin Cancer Res; 2002 Jul; 8(7):2369-77. PubMed ID: 12114442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.
    Hu YL; Tee MK; Goetzl EJ; Auersperg N; Mills GB; Ferrara N; Jaffe RB
    J Natl Cancer Inst; 2001 May; 93(10):762-8. PubMed ID: 11353786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI3K/Akt pathway and of IkappaB kinase activity.
    Bhattacharyya S; Sen P; Wallet M; Long B; Baldwin AS; Tisch R
    Blood; 2004 Aug; 104(4):1100-9. PubMed ID: 15113757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysophosphatidic acid stimulates cell growth by different mechanisms in SKOV-3 and Caov-3 ovarian cancer cells: distinct roles for Gi- and Rho-dependent pathways.
    Hurst JH; Hooks SB
    Pharmacology; 2009; 83(6):333-47. PubMed ID: 19420982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells.
    Wu SH; Lu C; Dong L; Zhou GP; He ZG; Chen ZQ
    Kidney Int; 2005 Jul; 68(1):35-46. PubMed ID: 15954894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysophosphatidic acid induces tumor necrosis factor-alpha to regulate a pro-inflammatory cytokine network in ovarian cancer.
    Wang W; Wu J; Mukherjee A; He T; Wang XY; Ma Y; Fang X
    FASEB J; 2020 Oct; 34(10):13935-13948. PubMed ID: 32851734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Requirement for NF-(kappa)B in interleukin-4-induced androgen receptor activation in prostate cancer cells.
    Lee SO; Lou W; Nadiminty N; Lin X; Gao AC
    Prostate; 2005 Jul; 64(2):160-7. PubMed ID: 15678501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulation of IL-1 receptor through PI3K/Akt is essential for the induction of iNOS gene expression in hepatocytes.
    Teshima S; Nakanishi H; Nishizawa M; Kitagawa K; Kaibori M; Yamada M; Habara K; Kwon AH; Kamiyama Y; Ito S; Okumura T
    J Hepatol; 2004 Apr; 40(4):616-23. PubMed ID: 15030977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rho-dependent, Rho kinase-independent inhibitory regulation of Rac and cell migration by LPA1 receptor in Gi-inactivated CHO cells.
    Sugimoto N; Takuwa N; Yoshioka K; Takuwa Y
    Exp Cell Res; 2006 Jun; 312(10):1899-908. PubMed ID: 16564043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.
    St-Germain ME; Gagnon V; Parent S; Asselin E
    Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.